Other Events ·
AC Immune SA announced on June 11, 2026, that it will receive a $4 million research grant from The Vijay and Marie…
ACIUAC Immune SA
AC Immune SA announced on June 11, 2026, that it will receive a $4 million research grant from The Vijay and Marie Goradia Charitable Foundation. This funding will support the extension of Part 1 of the ongoing Phase 2 VacSYn trial of ACI-7104, an anti-alpha-synuclein active immunotherapy for early Parkinson's disease. AC Immune SA is a biotechnology company focused on developing immunotherapy-based solutions for neurodegenerative diseases.